
Armata Pharmaceuticals, Inc.
ARMPHealthcare|Biotechnology|US
$3.51
+0.51 (+17.00%)
Cash / Share
$0.65
Next Earnings Report
Nov 11, 2026
EPS est. -$0.57 · Revenue est. $450.0K
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Dec 1, 2025 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with Two Recent Patent Issuances in the United States
Oct 7, 2026 · PRNewsWire
Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development
Sep 23, 2026 · PRNewsWire
Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates
Sep 21, 2026 · PRNewsWire
Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02
Sep 14, 2026 · PRNewsWire
Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026 · PRNewsWire
SEC Filings (57)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Sep 23, 2026 | 8-K | Material event | DocumentIndex |
| Sep 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Jul 20, 2026 | 8-K | Material event | DocumentIndex |
| Jul 20, 2026 | 8-K | Material event | DocumentIndex |
| Jul 13, 2026 | 8-K | Material event | DocumentIndex |
| Jul 13, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jun 24, 2026 | 8-K/A | Material event | DocumentIndex |
| Jun 23, 2026 | 8-K | Material event | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| May 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| Apr 27, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 27, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 27, 2026 | 8-K | Material event | DocumentIndex |
| Apr 2, 2026 | 8-K | Material event | DocumentIndex |
| Mar 25, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 25, 2026 | 8-K | Material event | DocumentIndex |
| Mar 19, 2026 | 8-K | Material event | DocumentIndex |
| Feb 23, 2026 | 8-K | Material event | DocumentIndex |
| Jan 26, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jan 26, 2026 | 8-K | Material event | DocumentIndex |
| Jan 13, 2026 | 8-K | Material event | DocumentIndex |
| Dec 1, 2025 | 8-K | Material event | DocumentIndex |
| Dec 1, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 12, 2025 | 8-K | Material event | DocumentIndex |
| Oct 22, 2025 | 8-K | Material event | DocumentIndex |
| Sep 11, 2025 | 8-K | Material event | DocumentIndex |
| Aug 22, 2025 | EFFECT | DocumentIndex | |
| Aug 13, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Aug 13, 2025 | S-3 | Shelf registration | DocumentIndex |
| Aug 12, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2025 | 8-K | Material event | DocumentIndex |
| Jun 13, 2025 | 8-K | Material event | DocumentIndex |
| May 19, 2025 | 8-K | Material event | DocumentIndex |